Home » Stocks » PARD

Poniard Pharmaceuticals, Inc. (PARD)

Stock Price: $0.0500 USD -0.0100 (-16.67%)
Updated Jan 15, 2021 11:56 AM EST - Market closed
Market Cap 287,808
Revenue (ttm) n/a
Net Income (ttm) n/a
Shares Out 1.50M
EPS (ttm) -3.79
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 15
Last Price $0.0500
Previous Close $0.0600
Change ($) -0.0100
Change (%) -16.67%
Day's Open 0.0500
Day's Range 0.0500 - 0.0500
Day's Volume 494
52-Week Range 0.03 - 0.1

News

There are no news available yet.

About PARD

Poniard Pharmaceuticals, a biopharmaceutical company, focuses on the development and commercialization of cancer therapeutics. Its lead platform product candidate includes Picoplatin, a platinum-based cancer therapy to treat multiple cancer indications, including small cell lung, colorectal, prostate, and ovarian cancers. The company has conducted a pivotal Phase III SPEAR trial of Picoplatin in the second-line treatment of patients with small cell lung cancer; Phase II trials evaluating picoplatin as a first-line treatment of metastatic colore... [Read more...]

Industry
Biotechnology
IPO Date
Aug 11, 1988
Stock Exchange
OTCMKTS
Ticker Symbol
PARD
Full Company Profile